Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term prognostic factors. Found 30 abstracts

no pagination
Meropol NJ, Feng Y, Grem JL, Mulcahy MF, Catalano PJ, Kauh JS, Hall MJ, Saltzman JN, George TJ, Zangmeister J, Chiorean EG, Cheema PS, O'Dwyer PJ, Benson AB. Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203). Cancer. 2018 Feb 15;124(4):688-97.   PMCID: PMC6226304
De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Crehange G, Alongi F, Zaorsky N, Ozsahin M. Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. The Prostate. 2017 Jul;77(10):1160-6.
Kaczmar JM, Tan KS, Heitjan DF, Lin A, Ahn PH, Newman JG, Rassekh CH, Chalian AA, O'Malley BW, Cohen RB, Weinstein GS. HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head & neck. 2016 Jan;38(1):59-65.
Freedman GM, Li TY, Polli LV, Anderson PR, Bleicher RJ, Sigurdson E, Swaby R, Dushkin H, Patchefsky A, Goldstein L. Lymphatic Space Invasion is Not an Independent Predictor of Outcomes in Early Stage Breast Cancer Treated by Breast-Conserving Surgery and Radiation. Breast Journal. 2012 Sep;18(5):415-9.
Mego M, De Giorgi U, Dawood S, Wang XM, Valero V, Andreopoulou E, Handy B, Ueno NT, Reuben JM, Cristofanilli M. Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells. International journal of cancer. 2011 Jul;129(2):417-23.   PMCID: not NIH funded
Kemeny NE, Niedzwiecki D, Hollis DR, Lenz HJ, Warren RS, Naughton MJ, Weeks JC, Sigurdson ER, Herndon JE, Zhang CF, Mayer RJ. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). JOURNAL OF CLINICAL ONCOLOGY. 2006 Mar;24(9):1395-403.
Gridelli C, Aapro M, Ardizzoni A, Balducci L, De Marinis F, Kelly K, Le Chevalier T, Manegold C, Perrone F, Rosell R, Shepherd F, De Petris L, Di Maio M, Langer C. Treatment of advanced non-small-cell lung cancer in the elderly: Results of an international expert panel. Journal of Clinical Oncology. 2005 May;23(13):3125-37.
Cianfrocca M, Goldstein LJ. Prognostic and predictive factors in early-stage breast cancer. The oncologist. 2004 Jan;9 (6):606-16.
Ibrahim D, Smith MR, Varterasian M, Karanes C, Millenson M, Yeslow G, Pemberton P, Lai P, Abrams J, Al-Katib A. Phase II study of PEND chemotherapy in patients with refractory/relapsed Hodgkin lymphoma. Leukemia & lymphoma. 2004 Oct;45(10):2079-84.
Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology. 2002 Jul;224(1):47-54.
Zekri AR, Bahnassi AA, Bove B, Huang YJ, Russo IH, Rogatko A, Shaarawy S, Shawki OA, Hamza MR, Omer S, Khaled HM, Russo J. Allelic instability as a predictor of survival in Egyptian breast cancer patients. International Journal of Oncology. 1999 Oct;15(4):757-67.
Green GA, Hanlon AL, Al-Saleem T, Hanks GE. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer. 1998 Sep;83(5):971-6.
Herold DM, Hanlon AL, Movsas B, Hanks GE. Age-related prostate cancer metastases. Urology. 1998 Jun;51(6):985-90.
Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman HP, Sigurdson ER, Jardines LA, Eisenberg BL. Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes. Journal of surgical oncology. 1997 May;65(1):34-9.
Algan O, Tabesh T, Hanlon A, Hogan WM, Boente M, Lanciano RM. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage with endometrial cancer. International Journal of Radiation Oncology Biology Physics. 1996 Jul 15;35(5):925-33.
Fein DA, Lee WR, Hanlon AL, Ridge JA, Curran WJ, Coia LR. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?. International Journal of Radiation Oncology Biology Physics. 1996 Mar;34(4):823-31.
Lattanzi J, Erickson B. Patterns of recurrence following hysterectomy and radiation for cervical carcinoma: Relationship to residual disease and brachytherapy techniques. International Journal of Gynecological Cancer. 1996 Sep;6(5):396-404.
Ahmad NR, Lanciano RM, Corn BW, Schultheiss T. Postoperative Radiation-Therapy for Surgically Staged Endometrial Cancer - Impact of Time Factors (Overall Treatment Time and Surgery-to-Radiation Interval) on Outcome. International Journal of Radiation Oncology Biology Physics. 1995 Nov;33(4):837-42.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ, Coia LR. Pretreatment Hemoglobin Level Influences Local-Control and Survival of T1-T2 Squamous-Cell Carcinomas of the Glottic Larynx. Journal of Clinical Oncology. 1995 Aug;13(8):2077-83.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term prognostic factors

prognostic factors radiotherapy adenocarcinoma survival chemotherapy multivariate-analysis cancer carcinoma term follow-up uterine cervix system predictive factors irinotecan adjuvant chemotherapy brachytherapy squamous-cell carcinoma dose-fractionation radiation therapy vocal cord carcinoma primary radiotherapy breast cancer surgery antigen thymidylate synthase radiation-therapy radiology and radiologists gene-expression progression relapsed Hodgkin lymphoma multimodal treatment complications induction perineal applicator mupit colony- clinical-trial breast-cancer fluorouracil plus leucovorin ii carcinoma efficacy study symptomatic treatment weekly docetaxel stimulating factor chromosome 13q12-q13 intrahepatic infusion cervical carcinoma prostate carcinoma lymphovascular invasion breast cancer-radiation therapy intraarterial floxuridine external irradiation erythropoietin randomized-trial stem-cell transplantation united-states oral vinorelbine tumor-suppressor gene axillary lymphadenopathy oropharynx chemotherapeutic embolization vaginal irradiation molecular markers mismatch repair deficiency internal mammary nodes local recurrences progenitor cells prostatic sarcoma single-agent experience treatment 5-fluorouracil heterozygosity anemia Oncology oropharyngeal postoperative irradiation specific antigen high-risk endometrial cancer cisplatin-based therapy activator inhibitor type-1 conservation therapy poor-prognosis metastases stage-i radical radiotherapy surgical adjuvant breast cancer-patients phase-i 1994 adha m-cancer-v73-p350 quality-of-life human papillomavirus (HPV) transoral robotic surgery (TORS) carcinomas autologous blood percutaneous ethanol injection geriatric oncology lymph-node metastases hysterectomy combination chemotherapy disease patients colorectal cancer gynecologic malignancies c-erbb-2 expression oxaliplatin old embolization pelvic therapy radiation- hemilaryngectomy brca2 radical-mastectomy epithelial-mesenchymal transition lymphadenectomy p16 prognostic factor circulating tumor cells-breast cancer adjuvant therapy gemcitabine plus vinorelbine breast conservation surgery first relapse endocrine therapy cesium region clinical stage high-dose chemotherapy radiation treatment time outcomes studies intraarterial bevacizumab stage-ib Gleason grade s-phase fraction ethiodized oil 1989 urquet a-international journal of radiation oncology biology physics-v17-p719 autologous bone-marrow randomized-trials tumor-cells follow-up endometrial cancer repopulation high-dose therapy prostate external pelvic irradiation median follow-up peripheral-blood lipiodol risk-factors factors mixture-models interstitial stage salvage therapy
Last updated on Tuesday, August 04, 2020